as on October 23, 2025 at 7:38 pm IST
Day's Low
Day's High
1.69%
Downside
3.95%
Upside
52 Week's Low
52 Week's High
37.85%
Downside
809.60%
Upside
Check Pliant Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$111.1M
EPS (TTM)
-2.8626
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-4.69
Industry PE ratio
-0.8798722044728434
PEG Ratio
0EBITDA
-218.0M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-67.55%
Track how Pliant Therapeutics Inc P/E has moved over time to understand its valuation trends.
Pliant Therapeutics Inc in the last 5 years
Lowest (-13.59x)
June 30, 2021
Today (-4.69x)
October 23, 2025
Industry (-0.88x)
October 23, 2025
Highest (-0.42x)
June 30, 2025
Today’s Price to Earnings Ratio: -4.69x
Compare market cap, revenue, PE, and other key metrics of Pliant Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $111.1M | -92.39% | -4.69 | 0.00% | |
BUY | $63.1B | 252.62% | -505.15 | -12.96% | |
NA | $35.3B | NA | NA | -3.89% | |
BUY | $109.3B | 101.55% | 30.36 | 31.86% | |
BUY | $61.3B | 0.85% | 14.6 | 31.37% |
The Pliant Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Pliant Therapeutics Inc investment value today
Current value as on today
₹17,109
Returns
Returns from Pliant Therapeutics Inc Stock
Dollar Returns*
₹4,653 (+4.65%)
Based on 20 analysts
95.00%
Buy
5.00%
Hold
0.00%
Sell
Based on 20 analysts, 95% of analysts recommend a 'BUY' rating for Pliant Therapeutics Inc. Average target price of $3.2
Get share price movements and forecasts by analysts on Pliant Therapeutics Inc.
What analysts predicted
44.69%UPSIDE
Target Price
$3.2
Current Price
$1.77
Analyzed by
20 Analysts
Target
$3.20
Pliant Therapeutics Inc target price $3.2, a slight upside of 44.69% compared to current price of $1.77. According to 20 analysts rating.
Search interest for Pliant Therapeutics Inc Stock has decreased by -5% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 7 days, PLRX stock has moved up by 9.7%
Profit Spike
Netprofit is up for the last 2 quarters, -56.16M → -43.3M (in $), with an average increase of 29.7% per quarter
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 133.8% return, outperforming this stock by 226.3%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 57.7% return, outperforming this stock by 145.0%
Revenue Fall
Revenue is down for the last 2 quarters, 4.83M → 2.27M (in $), with an average decrease of 53.1% per quarter
Organisation | Pliant Therapeutics Inc |
Headquarters | 331 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 |
Industry | Health Technology |
CEO | Dr. Bernard Coulie M.B.A., M.D., Ph.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Ms. Delphine Imbert Ph.D. | Chief Technical Officer |
Mr. Christopher S. Keenan | Vice President of Investor Relations & Corporate Communications |
Dr. Bernard Coulie M.B.A., M.D., Ph.D. | President, CEO & Director |
Dr. Eric A. Lefebvre M.D. | Chief Medical Officer |
Dr. Rik Derynck Ph.D. | Scientific Founder & Member of Scientific Advisory Board |
Mr. Dean Sheppard M.D. | Scientific Founder & Member of Scientific Advisory Board |
Mr. Bill DeGrado Ph.D. | Scientific Founder & Member of Scientific Advisory Board |
Mr. Hal Chapman M.D. | Scientific Founder & Member of Scientific Advisory Board |
Dr. Keith Lamont Cummings M.B.A., M.D. | Chief Financial Officer |
Mr. Johannes P. Hull J.D. | Chief Business Officer |
Pliant Therapeutics Inc share price today is $1.77 as on . Pliant Therapeutics Inc share today touched a day high of $1.84 and a low of $1.74.
Pliant Therapeutics Inc share touched a 52 week high of $16.1 on and a 52 week low of $1.1 on . Pliant Therapeutics Inc stock price today i.e. is trending at $1.77,which is 89.01% down from its 52 week high and 60.89% up from its 52 week low.
Pliant Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Pliant Therapeutics Inc (PLRX) shares with as little as ₹87.835 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.35 in Pliant Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Pliant Therapeutics Inc share’s latest price of $1.77 as on October 23, 2025 at 7:38 pm IST, you will get 5.6497 shares of Pliant Therapeutics Inc. Learn more about
fractional shares .
Pliant Therapeutics Inc stock has given -92.39% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?